Associate Professor of Oncology, Assistant Professor of Medicine, Johns Hopkins University School of Medicine; Associate Professor of Medicine and Oncology, Director, Myeloma Program, Division of Hematologic Malignancies
Oncology
Dr. Carol A. Huff, MD
|
|
Give Review
Carol A. Huff, MD is an expert in the field of Oncology. She attended Baylor College of Medicine. She over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Carol Huff is a published physician. She has 34 publications published. The most current publication "Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the n..."
Publications
- Persistence of variCella-zoster virus DNA in blood mononuclear Cells of patients with variCella or zoster.
- A human epidermal differentiation-specific keratin gene is regulated by calcium but not negative modulators of differentiation in transgenic mouse keratinocytes.
- Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the n...
- Recrudescence of cutaneous Mycobacterium haemophilum lesions following tetanus immunization.
- Salvage transplantation for alloGraft failure using fludarabine and alemtuzumab as conditioning regimen.
- Hedgehog signaling maintains a tumor stem Cell compartment in multiple myeloma.
- A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an Analysis of Ea...
- Comment on research report by Gruson and colleagues, this issue.
- Multiple Myeloma.
- High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell Lymphomas.
- Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple Myeloma.
- Telomerase inhibition targets clonogenic multiple myeloma Cells through telomere length-dependent and independent mechanisms.
- Lenalidomide-induced Acute interstitial nephritis.
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of Graft-versus-host disease.
- High-dose cyclophosphamide for severe aplastic Anemia: long-term follow-up.
- Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.
- NCCN clinical practice guidelines in oncology: multiple Myeloma.
- Multiple myeloma Cancer stem cells.
- HLA-haploidentical bone marrow transplantation for hematologic Malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
- Myeloablative allogeneic bone marrow transplant using T cell depleted alloGrafts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.
- Clonogenic multiple myeloma progenitors, stem Cell properties, and drug resistance.
- Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk Lymphoma.
- Multiple Myeloma. Clinical practice guidelines in oncology.
- Strategies to eliminate Cancer stem cells: clinical implications.
- Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
- The paradox of response and survival in Cancer therapeutics.
- Effects of imatinib and interferon on primitive Chronic myeloid leukaemia progenitors.
- Requirement for myeloid growth factors in the differentiation of Acute promyelocytic leukaemia.
- A phase II trial of temozolomide and IFN-alpha in patients with advanced renal cell Carcinoma.
- Characterization of clonogenic multiple myeloma Cells.
- Long-term follow-up of T Cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T Cells.
- Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor Cell differentiation.
- Bone marrow transplantation for multiple Myeloma: where we are today.
Schools
Baylor University
Johns Hopkins Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Baylor College of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1205882024 | |
| NPPES Provider LastName | HUFF | |
| NPPES Provider FirstName | CAROL | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 345.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205882024 |
| Last Name Of The Provider | HUFF |
| First Name Of The Provider | CAROL |
| View All |
Similar Doctors
|
|
Dr. Matthew J. Frigault, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danijela Jelovac, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard F. Ambinder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hetty E. Carraway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evan J. Lipson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul C. Celano, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Petr F. Hausner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marshall A. Levine, MD |
|
|
Dr. Yixing Jiang, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tanya M. Prowell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dung T. Le, MD |